BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Embryo
,
Early pregnancy factor
,
Clofibrate
,
rs7903146
,
CXCL2
,
Apoptosis
,
Hepatitis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SAS 6
Summary
General Info
Curated Studies
Most Correlated Studies
GSK cancer cell line transcript profiling
Tongue squamous cell carcinoma SAS cells with CYLD siRNA knockdown and treated with ALK5 inhibitor
Uterine sarcoma MES-SA xenograft primary tumors from sublines selected for high metastasis potential
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
The dimeric Golgi protein Gorab binds to Sas6 as a monomer to mediate centriole duplication.
The Singularity of the Drosophila Male Germ Cell Centriole: The Asymmetric Distribution of Sas4 and …
Interaction interface in the C-terminal parts of centriole proteins Sas6 and Ana2.
Two-step phosphorylation of Ana2 by Plk4 is required for the sequential loading of Ana2 and Sas6 to …
SAPs as a new model to probe the pathway of centriole and centrosome assembly.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency
Immunogenicity of SA 14-14-2 JE Vaccine
A Phase 2 Study to Evaluate the Dose and Pharmacodynamic Efficacy of Sialic Acid-Extended Release (S…
A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Pancreatic Exocrine Insuf…
An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid-Extended Release (SA-ER) Tablets an…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ